Ethics group demands donor disclosure for $400 million White House ballroom

A federal judge is poised to decide whether the White House can rely on private fundraising to complete a roughly $400 million ballroom project, even as an ethics group demands full public disclosure of donors whose contributions could shape policy and public trust.

The White House has acknowledged it compiled a list of 37 donors to finance the ballroom but has not released the amounts each gave and has said it will allow contributors to remain anonymous if they wish. The East Wing was being demolished last fall to make way for the new construction, and the administration has framed private donations as a way to avoid a taxpayer burden. President Donald Trump told supporters that “we’ve raised I think $350 million, all donor money and money that we put up, we’ve raised,” language cited by ethics watchdogs as evidence of active private fundraising.

The National Trust for Historic Preservation sued in December to halt construction, arguing that the president may lack the statutory authority to demolish and reconfigure the East Wing and to proceed without congressional approval. A hearing in January before U.S. District Judge Ricard Leon left the court with pointed questions about whether the administration can legally sidestep Congress; Judge Leon signaled reservations about proceeding without explicit legislative authorization and may rule this month.

The dispute has reignited concerns about private money shaping public spaces and policy priorities. Citizens for Responsibility and Ethics in Washington, or CREW, reviewed disclosures and lobbying rules and concluded that at least 23 of the reported contributors should have reported their donations in regular lobbying disclosure filings. CREW noted that only one company publicly known to have given, Vantive Healthcare, disclosed its donation in a 2025 year-end lobbying contribution report filed “last month,” while most other donors have declined to say how much they have given. Reported corporate contributors include large technology firms such as Amazon, Apple, Google, and Microsoft, though the White House has not confirmed amounts.

CREW framed the omission as more than a paperwork problem. “Even if there is disagreement about whether the ballroom donations qualify under section 203, the contributions, which have sparked intense public interest and raise serious corruption concerns, clearly meet the spirit of the disclosure rules and the donors who otherwise file lobbying contribution reports should act as though they are required to be disclosed,” the organization wrote, adding that Congress should update rules and guidance to make clear these types of contributions must be reported publicly.

Legal and transparency questions carry consequences for healthcare policy and communities that rely on accountable governance. Private donors that are also regulated industries or major employers can have incentives to shape executive priorities on issues ranging from drug pricing and health care regulation to data privacy and AI in medicine. Without transparent disclosure and congressional oversight, critics warn, policymaking risk tilting toward narrow corporate interests rather than public health needs and social equity.

As the court readies a ruling, CREW has urged Congress to tighten disclosure rules and invited public support to sustain its work demanding accountability. The White House’s donor list and the lobbying filings that might clarify who gave what remain central pieces of evidence for both the legal challenge and for the broader debate over whether private financing of the executive mansion’s expansion undermines democratic oversight and equitable policy outcomes.